---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-305948"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2023-12-29T23:59:59+00:00"
generated_at: "2026-06-07T05:59:26.855882+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Renalytix receives Nasdaq deficiency notices for bid price and market value

## Summary
- ADS closing bid below $1.00 for 30+ consecutive days, violating Minimum Bid Price Requirement.
- Market value of listed securities below $50M threshold for continued Nasdaq Global Market listing.
- Company has 180-day compliance period until June 19, 2024 to cure both deficiencies.
- Failure may lead to delisting or transfer to Nasdaq Capital Market with additional cure period.
- Company will monitor and may pursue options to regain compliance; no assurance of success.

## SEC filing metadata
- accession: 0001193125-23-305948
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2023-12-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000119312523305948/0001193125-23-305948-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000119312523305948/d736040d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-305948
- JSON: https://secwatch.observer/filing/0001193125-23-305948.json
- Plain text: https://secwatch.observer/filing/0001193125-23-305948.txt

## Key facts
- Listing & Compliance Notices
  Renalytix plc received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5450(b)(2)(A)
  source text: December 22, 2023, Renalytix plc (the “Company”) received two written notices (the “Notices”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that (i) because the closing bid price for the Company’s American Depositary Shares (“ADSs”), each representing two ordinary shares, nominal value £0.0025 per share, was below $1.00 per ADS for at least 30 consecutive business days, the Company did not meet the $1.00 per ADS minimum bid price requirement of Nasdaq Listing Rule 5450(a)(1) the (“Minimum Bid Price Requirement”) and (ii) it is not in
  evidence_url: https://www.sec.gov/Archives/edgar/data/1811115/000119312523305948/0001193125-23-305948-index.htm
- Listing & Compliance Notices
  Renalytix plc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: December 22, 2023, Renalytix plc (the “Company”) received two written notices (the “Notices”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that (i) because the closing bid price for the Company’s American Depositary Shares (“ADSs”), each representing two ordinary shares, nominal value £0.0025 per share, was below $1.00 per ADS for at least 30 consecutive business days, the Company did not meet the $1.00 per ADS minimum bid price requirement of Nasdaq Listing Rule 5450(a)(1) the (“Minimum Bid Price Requirement”) and (ii) it is not in
  evidence_url: https://www.sec.gov/Archives/edgar/data/1811115/000119312523305948/0001193125-23-305948-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.